Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Finished Goods (2016 - 2021)

Historic Finished Goods for Medifast (MED) over the last 9 years, with Q3 2021 value amounting to $100.7 million.

  • Medifast's Finished Goods rose 38759.32% to $100.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $100.7 million, marking a year-over-year increase of 38759.32%. This contributed to the annual value of $29.9 million for FY2020, which is 464.97% down from last year.
  • Medifast's Finished Goods amounted to $100.7 million in Q3 2021, which was up 38759.32% from $73.1 million recorded in Q2 2021.
  • Medifast's 5-year Finished Goods high stood at $100.7 million for Q3 2021, and its period low was $10.5 million during Q3 2017.
  • For the 5-year period, Medifast's Finished Goods averaged around $30.3 million, with its median value being $27.5 million (2018).
  • Its Finished Goods has fluctuated over the past 5 years, first tumbled by 3884.38% in 2020, then surged by 38759.32% in 2021.
  • Over the past 5 years, Medifast's Finished Goods (Quarter) stood at $13.4 million in 2017, then skyrocketed by 90.27% to $25.5 million in 2018, then increased by 22.76% to $31.3 million in 2019, then decreased by 4.65% to $29.9 million in 2020, then skyrocketed by 237.22% to $100.7 million in 2021.
  • Its last three reported values are $100.7 million in Q3 2021, $73.1 million for Q2 2021, and $40.5 million during Q1 2021.